Zealand Pharma A/S ZLDPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.07% | -30.58% | -42.07% | -61.31% | 2,827.10% |
| Total Depreciation and Amortization | 31.54% | 122.05% | 41.97% | 24.03% | 9.12% |
| Total Amortization of Deferred Charges | -- | -- | 34.81% | -- | -- |
| Total Other Non-Cash Items | -96.49% | -188.82% | -3,295.02% | 762.42% | 1,045.86% |
| Change in Net Operating Assets | -915.71% | -71.75% | 342.22% | -978.81% | 5,085.68% |
| Cash from Operations | -95.12% | -48.92% | -530.18% | -59.73% | 3,982.77% |
| Capital Expenditure | -90.00% | -85.03% | -1,461.81% | -1,438.54% | -44.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.40% | -120.98% | -318.10% | 85.09% | -6,425.68% |
| Cash from Investing | 114.49% | -123.20% | -329.92% | 85.03% | -5,357.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -60.00% | -125.00% | -30.44% | -29.57% | -30.89% |
| Issuance of Common Stock | -59.26% | -66.67% | 20,418.52% | -62.82% | -99.62% |
| Repurchase of Common Stock | -31.93% | -- | -- | 72.39% | -309.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -43.56% | -787.95% | 351.95% | 69.43% | -104.85% |
| Foreign Exchange rate Adjustments | 96.94% | 2,616.42% | 184.83% | 5,865.50% | -18,710.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.01% | -1,716.49% | -35,181.24% | 79.66% | 5.18% |